What medication regimen is appropriate for severe agitation and delirium in a restrained patient with hypocalcemia (serum calcium 5.6 mg/dL) and elevated creatine kinase?

Management of Severe Agitation and Delirium in a Restrained Patient with Hypocalcemia and Elevated CK

Immediately correct the severe hypocalcemia (5.6 mg/dL) with intravenous calcium infusion while simultaneously managing agitation with haloperidol 0.5-2 mg IV/IM every 1 hour as needed, adding lorazepam 0.5-2 mg IV/IM only if agitation remains refractory to antipsychotic monotherapy.

Critical First Priority: Address the Hypocalcemia

The serum calcium of 5.6 mg/dL represents severe, life-threatening hypocalcemia that can directly cause delirium, agitation, neuromuscular irritability, and seizures 1. This metabolic derangement is likely a primary driver of the patient's symptoms and must be corrected emergently.

• Administer IV calcium gluconate or calcium chloride immediately to raise calcium levels and resolve neuropsychiatric symptoms 1
• The elevated CK suggests rhabdomyolysis, which commonly causes hypocalcemia through calcium deposition in damaged muscle tissue and hyperphosphatemia 2
• Hypocalcemia from magnesium therapy or other causes can directly manifest as delirium with myoclonus 3
• Do not rely solely on sedation when a correctable metabolic cause exists

Pharmacologic Management of Severe Agitation

While correcting the hypocalcemia, concurrent pharmacologic control of dangerous agitation is necessary:

First-Line: Antipsychotic Monotherapy

Haloperidol remains the preferred agent for severe delirium with agitation 4, 5:

• Start with haloperidol 0.5-2 mg IV or IM every 1 hour PRN until the episode is under control 4
• For severe distress or immediate danger, consider starting with 1.5-3 mg 6
• Can be given IV (requires ECG monitoring), IM, or subcutaneously 5
• Maximum 10 mg daily (5 mg in elderly patients) 6

Alternative antipsychotics if haloperidol is contraindicated:

• Olanzapine 2.5-5 mg IM/SC (avoid combining with benzodiazepines due to respiratory depression risk) 5
• Quetiapine 50-100 mg PO if patient can swallow 4

Second-Line: Add Benzodiazepine Only if Refractory

If agitation persists despite adequate antipsychotic dosing, add lorazepam 4, 7:

• Lorazepam 0.5-2 mg IV/IM every 4-6 hours PRN 4
• Or midazolam 2.5-5 mg IV/SC every 2-4 hours PRN 5, 6
• Use lower doses (0.25-0.5 mg lorazepam or 0.5-1 mg midazolam) in elderly/frail patients or when combining with antipsychotics 5, 6

Critical caveat: Benzodiazepines alone may worsen delirium and should not be first-line unless this is alcohol or benzodiazepine withdrawal 5, 8. The combination of haloperidol plus lorazepam may produce more rapid sedation than monotherapy 7.

Important Safety Considerations

QTc Prolongation Risk

• Check baseline ECG before haloperidol administration 5, 8
• Avoid antipsychotics in patients with baseline QTc prolongation, concomitant QTc-prolonging medications, or history of torsades de pointes 8
• Haloperidol can prolong QTc interval, though evidence for causing severe cardiac events is not convincing 7

Rhabdomyolysis Context

The elevated CK indicates ongoing muscle damage, which:

• Directly causes hypocalcemia through calcium deposition and hyperphosphatemia 2
• May worsen with physical restraints causing continued muscle injury
• Requires aggressive IV hydration to prevent acute kidney injury 2
• AKI would further exacerbate hypocalcemia by impairing phosphate excretion 2

Avoid These Pitfalls

• Do not use benzodiazepines as monotherapy - they are a risk factor for delirium development 8
• Do not use rivastigmine - it increases delirium duration and mortality in critically ill patients 8
• Do not routinely use antipsychotics for delirium prevention, but they are appropriate for treatment of severe agitation 9
• Minimize physical restraints as they may worsen rhabdomyolysis and agitation 7

Algorithmic Approach

1. Immediate (within minutes):

   • IV calcium gluconate/chloride for severe hypocalcemia
   • Haloperidol 0.5-2 mg IV/IM (check ECG first if possible)
   • Aggressive IV hydration for rhabdomyolysis

2. If inadequate response after 1 hour:

   • Repeat haloperidol 0.5-2 mg IV/IM
   • Titrate upward as needed

3. If still refractory after adequate antipsychotic dosing:

   • Add lorazepam 0.5-2 mg IV/IM
   • Consider combination therapy 7

4. Ongoing management:

   • Monitor calcium levels and replace as needed
   • Monitor CK, renal function, phosphate
   • Transition to scheduled dosing if symptoms persist (haloperidol 0.5-1 mg q8-12h) 4
   • Reassess and treat any other reversible causes of delirium 8

The metabolic correction is as important as the sedation - failure to address the hypocalcemia will result in persistent symptoms despite adequate pharmacologic management 3, 1.